ClinicalTrials.gov
ClinicalTrials.gov Menu

Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00355407
Recruitment Status : Completed
First Posted : July 21, 2006
Last Update Posted : March 13, 2009
Sponsor:
Collaborators:
Amgen
Brigham and Women's Hospital
Information provided by:
Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2007
  Actual Study Completion Date : August 2007